Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment.
Hjalmarsson C, Kjellström B, Jansson K, Nisell M, Kylhammar D, Kavianipour M, Rådegran G, Söderberg S, Wikström G, Wuttge DM, Hesselstrand R. Hjalmarsson C, et al. Among authors: jansson k. ERJ Open Res. 2021 Aug 2;7(3):00854-2020. doi: 10.1183/23120541.00854-2020. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34350280 Free PMC article.
Longitudinal changes in risk status in pulmonary arterial hypertension.
Bouzina H, Rådegran G, Butler O, Hesselstrand R, Hjalmarsson C, Holl K, Jansson K, Klok R, Söderberg S, Kjellström B. Bouzina H, et al. Among authors: jansson k. ESC Heart Fail. 2021 Feb;8(1):680-690. doi: 10.1002/ehf2.13162. Epub 2020 Dec 10. ESC Heart Fail. 2021. PMID: 33305545 Free PMC article.
Predicting mortality during long-term follow-up in pulmonary arterial hypertension.
Kylhammar D, Hjalmarsson C, Hesselstrand R, Jansson K, Kavianipour M, Kjellström B, Nisell M, Söderberg S, Rådegran G. Kylhammar D, et al. Among authors: jansson k. ERJ Open Res. 2021 May 31;7(2):00837-2020. doi: 10.1183/23120541.00837-2020. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 34084789 Free PMC article.
Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
Rådegran G, Kjellström B, Ekmehag B, Larsen F, Rundqvist B, Blomquist SB, Gustafsson C, Hesselstrand R, Karlsson M, Kornhall B, Nisell M, Persson L, Ryftenius H, Selin M, Ullman B, Wall K, Wikström G, Willehadson M, Jansson K; Stefan Söderberg j , on behalf of SveFPH and SPAHR. Rådegran G, et al. Among authors: jansson k. Scand Cardiovasc J. 2016 Aug;50(4):243-50. doi: 10.1080/14017431.2016.1185532. Epub 2016 Jun 14. Scand Cardiovasc J. 2016. PMID: 27146648
Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy: a registry-based study.
Hjalmarsson C, Butler O, Hesselstrand R, Holl K, Jansson K, Klok R, Rådegran G, Söderberg S, Kjellström B. Hjalmarsson C, et al. Among authors: jansson k. Pulm Circ. 2020 Sep 28;10(3):2045894020958557. doi: 10.1177/2045894020958557. eCollection 2020 Jul-Sep. Pulm Circ. 2020. PMID: 33062261 Free PMC article.
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension.
Kjellström B, Bouzina H, Björklund E, Beaudet A, Edwards SC, Hesselstrand R, Jansson K, Nisell M, Rådegran G, Sandqvist A, Wåhlander H, Hjalmarsson C, Söderberg S. Kjellström B, et al. Among authors: jansson k. ESC Heart Fail. 2022 Oct;9(5):3264-3274. doi: 10.1002/ehf2.14033. Epub 2022 Jul 4. ESC Heart Fail. 2022. PMID: 35789127 Free PMC article.
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study.
Gustafsson F, Andreassen AK, Andersson B, Eiskjær H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L; SCHEDULE (Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance) Investigators*. Gustafsson F, et al. Among authors: jansson k. Transplantation. 2020 Jan;104(1):154-164. doi: 10.1097/TP.0000000000002702. Transplantation. 2020. PMID: 30893292 Clinical Trial.
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE).
Relbo Authen A, Grov I, Karason K, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Dellgren G, Solbu D, Arora S, Andreassen AK, Gullestad L. Relbo Authen A, et al. Among authors: jansson k. Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13038. Epub 2017 Jul 19. Clin Transplant. 2017. PMID: 28640529 Clinical Trial.
278 results